Thanks to products sourced from its pharmaceutical know how and to an on going desire to target more innovative therapeutic sectors, Ethypharm has been able to increase its development portfolio within the context of a rich and diversified programme.
The R&D teams work to develop the best adaptated pharmaceutical forms with appropriate administration systems to meet the public demand.
Today, with a portfolio of more than 30 projects in development, Ethypharm disposes of a range of products amongst the richest and most diversified on the market of controlled release medecines by the oral route.
Fentanyl
Hydromorphone
Oxycodone
Fenofibrate – Atorvastatin
Donepezil
Esomeprazole
Tamsulosine
Tolterodine
Sildenafil
